CMV-CMI in csCMVi After HSCT

Abroad (travel likely)Recruiting

Conditions

Cytomegalovirus Infections · Hematopoietic Stem Cell Transplantation (HSCT) · Immune Reconstitution

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (The First Affiliated Hospital of Soochow University) · sdfyec@163.com · +86 512 67972861

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

Cytomegalovirus Infections · Cytomegalovirus Disease · Hematopoietic Stem Cell Transplantation

Abroad (travel likely)RecruitingPHASE4

Beijing, China · Shijiazhuang, China

T Cell Therapy of Opportunistic Cytomegalovirus Infection

Cytomegalovirus Infections · Hematopoietic Stem Cell Transplant · Opportunistic Infections

Abroad (travel likely)RecruitingEARLY_PHASE1

Cleveland, United States

Evaluation of CMV/EBV-CMI in Haploid HSCT

Hematopoietic Stem Cell Transplantation · Cytomegalovirus Infections · Epstein-Barr Virus Infections

Abroad (travel likely)Recruiting

Suzhou, China

Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients

Cytomegalovirus Infections

Abroad (travel likely)Recruiting

Houston, United States · Brussels, Belgium